Diffusion Pharmaceuticals Inc. Human Resources Contracts & Agreements
52 Contracts & Agreements
- Bonus & Incentive Agreements (5 contracts)
- Consulting Agreements (5)
- Employment Agreements (31)
- Separation Agreements (10)
- Severance Agreements (1)
- Consulting Agreement, effective as of June 1, 2024, by and between the CervoMed Inc. and J. William Tanner, Ph.D (Filed With SEC on August 9, 2024)
- Separation Agreement, effective as of May 31, 2024, by and between the CervoMed Inc. and J. William Tanner, Ph.D (Filed With SEC on August 9, 2024)
- Amended & Restated Employment Agreement, effective as of June 1, 2024, by and between CervoMed Inc. and William Elder (Filed With SEC on August 9, 2024)
- Form of Consulting Agreement, effective as of June 1, 2024, by and between the Company and J. William Tanner, Ph.D (Filed With SEC on May 20, 2024)
- Form of Separation Agreement, effective as of May 31, 2024, by and between the Company and J. William Tanner, Ph.D (Filed With SEC on May 20, 2024)
- Form of Amended & Restated Employment Agreement, effective as of June 1, 2024, by and between the Company and William Elder (Filed With SEC on May 20, 2024)
- Employment Agreement, dated February 1, 2024, by and between CervoMed Inc. and Kelly Blackburn, M.H.A (Filed With SEC on February 2, 2024)
- Amended & Restated Employment Agreement, dated February 1, 2024, by and between CervoMed Inc. and Robert J. Cobuzzi, Jr., Ph.D (Filed With SEC on February 2, 2024)
- Amended & Restated Employment Agreement, dated February 1, 2024, by and between CervoMed Inc. and John Alam, M.D (Filed With SEC on February 2, 2024)
- Employment Agreement, dated November 15, 2023, by and between CervoMed Inc. and J. William Tanner (Filed With SEC on November 17, 2023)
- Separation Agreement and General Release, dated May 15, 2023, by and between Diffusion Pharmaceuticals Inc. and William K. Hornung (Filed With SEC on May 19, 2023)
- 2018 Employee, Director and Consultant Equity Incentive Plan, effective as of March 28, 2019 (Filed With SEC on May 11, 2023)
- Executive Employment Agreement, effective as of April 2, 2018, by and between EIP Pharma, Inc., and John Alam, M.D (Filed With SEC on May 11, 2023)
- Amendment No. 1, dated as of March 4, 2019, to Executive Employment Agreement, dated as of April 2, 2018, by and between EIP Pharma, Inc., and Sylvie Gregoire (Filed With SEC on May 11, 2023)
- Executive Employment Agreement, dated as of April 2, 2018, by and between EIP Pharma, Inc., and Sylvie Gregoire (Filed With SEC on May 11, 2023)
- Amendment, dated March 29, 2023, to Employment Agreement, dated September 23, 2020, by and between Diffusion Pharmaceuticals Inc. and William Elder (Filed With SEC on March 30, 2023)
- Amendment, dated March 29, 2023, to Employment Agreement, dated September 21, 2018, by and between Diffusion Pharmaceuticals Inc. and William Hornung (Filed With SEC on March 30, 2023)
- Amendment, dated March 29, 2023, to Employment Agreement, dated September 8, 2020, by and between Diffusion Pharmaceuticals Inc. and Robert J. Cobuzzi, Ph.D (Filed With SEC on March 30, 2023)
- Separation Agreement and General Release, effective as of March 8, 2023, by and between Diffusion Pharmaceuticals and Raven Jaeger (Filed With SEC on March 24, 2023)
- Separation Agreement and General Release, effective as of March 8, 2023, by and between Diffusion Pharmaceuticals and Christopher D. Galloway, M.D (Filed With SEC on March 24, 2023)
- Form of Separation Agreement and General Release by and between Diffusion Pharmaceuticals Inc. and certain executive employees (Filed With SEC on February 16, 2023)
- Employment Agreement, effective May 18, 2022, by and between the Company and Raven Jaeger, M.S (Filed With SEC on June 28, 2022)
- Form of Director RSU Agreement under 2015 Equity Incentive Plan (Filed With SEC on March 18, 2022)
- Form of Stock Option Award Agreement under 2015 Equity Incentive Plan (Filed With SEC on March 18, 2022)
- Employment Agreement, dated as of October 19, 2020, by and between Diffusion Pharmaceuticals Inc. and Christopher D. Galloway (Filed With SEC on October 20, 2020)
- Employment Agreement, dated as of September 23, 2020, by and between Diffusion Pharmaceuticals Inc. and William R. Elder (Filed With SEC on September 25, 2020)
- Employment Agreement, dated as of September 8, 2020, by and between Diffusion Pharmaceuticals Inc. and Robert J. Cobuzzi, Ph.D (Filed With SEC on September 9, 2020)
- Separation Agreement, dated as of September 8, 2020, by and between Diffusion Pharmaceuticals Inc. and David G. Kalergis (Filed With SEC on September 9, 2020)
- Consulting Agreement, dated March 12, 2020, by and between Diffusion Pharmaceuticals Inc. and John L. Gainer (Filed With SEC on March 18, 2020)
- Separation Agreement, dated March 12, 2020, by and between Diffusion Pharmaceuticals Inc. and John L. Gainer (Filed With SEC on March 18, 2020)
- Separation Letter, effective as of September 26, 2018, by and between Ben L. Shealy and Diffusion Pharmaceuticals Inc (Filed With SEC on September 27, 2018)
- Amended and Restated Employment Agreement, dated as of September 21, 2018, by and between William Hornung and Diffusion Pharmaceuticals Inc (Filed With SEC on September 27, 2018)
- EMPLOYMENT AGREEMENT (Filed With SEC on October 13, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on September 8, 2016)
- INCENTIVE STOCK OPTION AGREEMENT (Filed With SEC on June 18, 2015)
- RESTORGENEX CORPORATION 2015 EQUITY INCENTIVE PLAN (Filed With SEC on June 18, 2015)
- Addendum to Executive Employment Agreement of David Sherris (Filed With SEC on November 12, 2014)
- CONSULTING AGREEMENT (Filed With SEC on November 12, 2014)
- Addendum to Executive Employment Agreement of Yael Schwartz (Filed With SEC on August 14, 2014)
- SEVERANCE AGREEMENT AND GENERAL RELEASE (Filed With SEC on June 9, 2014)
